Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash to Debt 2293.15
OPHLY's Cash to Debt is ranked higher than
80% of the 750 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.39 vs. OPHLY: 2293.15 )
OPHLY' s 10-Year Cash to Debt Range
Min: 699.62   Max: 11991.36
Current: 2293.15

699.62
11991.36
Equity to Asset 0.94
OPHLY's Equity to Asset is ranked higher than
98% of the 712 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 0.60 vs. OPHLY: 0.94 )
OPHLY' s 10-Year Equity to Asset Range
Min: 0.93   Max: 0.95
Current: 0.94

0.93
0.95
Interest Coverage 15960.50
OPHLY's Interest Coverage is ranked higher than
99% of the 462 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 90.51 vs. OPHLY: 15960.50 )
OPHLY' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: 15960.5

F-Score: 4
Z-Score: 18.70
M-Score: -2.46
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 21.95
OPHLY's Operating margin (%) is ranked higher than
91% of the 713 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 9.34 vs. OPHLY: 21.95 )
OPHLY' s 10-Year Operating margin (%) Range
Min: 21.95   Max: 31.83
Current: 21.95

21.95
31.83
Net-margin (%) 16.59
OPHLY's Net-margin (%) is ranked higher than
88% of the 713 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 7.50 vs. OPHLY: 16.59 )
OPHLY' s 10-Year Net-margin (%) Range
Min: 16.59   Max: 20.5
Current: 16.59

16.59
20.5
ROE (%) 5.61
OPHLY's ROE (%) is ranked higher than
67% of the 716 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 7.00 vs. OPHLY: 5.61 )
OPHLY' s 10-Year ROE (%) Range
Min: 5.61   Max: 6.8
Current: 5.61

5.61
6.8
ROA (%) 5.29
OPHLY's ROA (%) is ranked higher than
77% of the 745 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 3.95 vs. OPHLY: 5.29 )
OPHLY' s 10-Year ROA (%) Range
Min: 5.29   Max: 6.43
Current: 5.29

5.29
6.43
ROC (Joel Greenblatt) (%) 29.43
OPHLY's ROC (Joel Greenblatt) (%) is ranked higher than
87% of the 735 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 14.63 vs. OPHLY: 29.43 )
OPHLY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 29.43   Max: 49.05
Current: 29.43

29.43
49.05
» OPHLY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

OPHLY Guru Trades in

OPHLY Guru Trades in

OPHLY Guru Trades in

Q3 2012

OPHLY Guru Trades in Q3 2012

Vanguard Health Care Fund 960,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with OPHLY



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 29.60
OPHLY's P/E(ttm) is ranked higher than
63% of the 527 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 25.60 vs. OPHLY: 29.60 )
OPHLY' s 10-Year P/E(ttm) Range
Min: 16.92   Max: 43.78
Current: 29.6

16.92
43.78
P/S 5.83
OPHLY's P/S is ranked lower than
64% of the 717 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.95 vs. OPHLY: 5.83 )
OPHLY' s 10-Year P/S Range
Min: 2.89   Max: 6.4
Current: 5.83

2.89
6.4
EV-to-EBIT 22.70
OPHLY's EV-to-EBIT is ranked higher than
59% of the 593 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 19.45 vs. OPHLY: 22.70 )
OPHLY' s 10-Year EV-to-EBIT Range
Min: 6.9   Max: 31.2
Current: 22.7

6.9
31.2

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.96
OPHLY's Dividend Yield is ranked higher than
67% of the 418 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.38 vs. OPHLY: 0.96 )
OPHLY' s 10-Year Dividend Yield Range
Min: 2.16   Max: 4.24
Current: 0.96

2.16
4.24
Dividend Payout 0.36
OPHLY's Dividend Payout is ranked higher than
58% of the 376 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 0.33 vs. OPHLY: 0.36 )
OPHLY' s 10-Year Dividend Payout Range
Min: 1.28   Max: 231.43
Current: 0.36

1.28
231.43
Yield on cost (5-Year) 1.00
OPHLY's Yield on cost (5-Year) is ranked higher than
71% of the 429 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.44 vs. OPHLY: 1.00 )
OPHLY' s 10-Year Yield on cost (5-Year) Range
Min: 2.16   Max: 4.24
Current: 1

2.16
4.24

Valuation & Return

vs
industry
vs
history
Price/Net Cash 981.30
OPHLY's Price/Net Cash is ranked higher than
58% of the 219 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 12.70 vs. OPHLY: 981.30 )
OPHLY' s 10-Year Price/Net Cash Range
Min: 4.38   Max: 6.17
Current: 981.3

4.38
6.17
Price/Net Current Asset Value 17.70
OPHLY's Price/Net Current Asset Value is ranked higher than
66% of the 317 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 9.80 vs. OPHLY: 17.70 )
OPHLY' s 10-Year Price/Net Current Asset Value Range
Min: 3.27   Max: 4.21
Current: 17.7

3.27
4.21
Price/Tangible Book 1.90
OPHLY's Price/Tangible Book is ranked higher than
79% of the 639 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 4.10 vs. OPHLY: 1.90 )
OPHLY' s 10-Year Price/Tangible Book Range
Min: 1.1   Max: 1.42
Current: 1.9

1.1
1.42
Price/Median PS Value 1.70
OPHLY's Price/Median PS Value is ranked lower than
55% of the 675 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.10 vs. OPHLY: 1.70 )
OPHLY' s 10-Year Price/Median PS Value Range
Min: 0.92   Max: 1.82
Current: 1.7

0.92
1.82
Price/Graham Number 1.80
OPHLY's Price/Graham Number is ranked higher than
65% of the 470 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.20 vs. OPHLY: 1.80 )
OPHLY' s 10-Year Price/Graham Number Range
Min: 0.93   Max: 1.25
Current: 1.8

0.93
1.25
Earnings Yield (Greenblatt) 4.40
OPHLY's Earnings Yield (Greenblatt) is ranked higher than
66% of the 595 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 4.80 vs. OPHLY: 4.40 )
OPHLY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.2   Max: 14.5
Current: 4.4

3.2
14.5

Business Description

Industry: Drug Manufacturers » Drug Manufacturers - Major
Compare: » details
Traded in other countries:4528.Japan, 4528.Japan
Ono Pharmaceutical Co., Ltd.. is primarily engaged in the manufacture and sale of pharmaceuticals. The Company offers oral medication for the treatment of bronchial asthma, disturbances of peripheral circulation etc.
» More Articles for OTCPK:OPHLY

Headlines

Articles On GuruFocus.com
No related article found.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide